Jeremy Grantham Lensar, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.8 - $8.2 $58,336 - $82,475	-10,058 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$5.9 - $7.84 $114,855 - $152,621	-19,467 Reduced 65.93%	10,058 $60,000
Q3 2021 Nov 12, 2021	SELL	$7.5 - $8.88 $18,000 - $21,312	-2,400 Reduced 7.52%	29,525 $232,000
Q2 2021 Aug 12, 2021	SELL	$6.87 - $8.66 $25,954 - $32,717	-3,778 Reduced 10.58%	31,925 $276,000
Q1 2021 May 13, 2021	SELL	$6.28 - $9.56 $15,894 - $24,196	-2,531 Reduced 6.62%	35,703 $259,000
Q4 2020 Feb 12, 2021	BUY	$6.7 - $12.2 $256,167 - $466,454	38,234 New	38,234 $277,000

5.05M

58.3K

19K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $150M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.